<DOC>
	<DOCNO>NCT01543204</DOCNO>
	<brief_summary>This study evaluate efficacy etanercept patient plaque psoriasis lose satisfactory response adalimumab .</brief_summary>
	<brief_title>Etanercept Treatment Patients With Moderate Severe Plaque Psoriasis Who Lost Response Adalimumab</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>Moderate severe plaque psoriasis Loss satisfactory response adalimumab Currently receive recently discontinue treatment adalimumab Active skin condition would interfere evaluation effect investigational product psoriasis Serious medical condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>plaque psoriasis</keyword>
	<keyword>etanercept</keyword>
	<keyword>adalimumab</keyword>
</DOC>